Clinical Trial Update: Chemoembolization With or Without Stereotactic Body Radiosurgery for Liver Cancer [NA]

View source ↗

Summary

The clinical trial NCT02304445 evaluating chemoembolization with or without stereotactic body radiotherapy for hepatocellular carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Juan Sanabria, MD | Conditions: Carcinoma, Hepatocellular | NA | Status: WITHDRAWN